DES Pharma Consulting and Adept Packaging Announce Strategic Alliance to Integrate CMC Strategy with Pharmaceutical Packaging Execution

New York, NY— DES Pharma Consulting and Adept Packaging today announced a strategic alliance designed to bridge a critical gap in pharmaceutical development: the alignment between CMC strategy, quality systems, and packaging execution. The collaboration, formalized in May 2026, establishes a coordinated model in which both organizations work alongside shared clients from early development through commercial launch — ensuring that packaging strategy is embedded into program planning from the outset rather than addressed as a downstream activity. 

The pharmaceutical industry continues to face pressure to compress development timelines without compromising quality or regulatory integrity. Packaging decisions — container closure systems, material qualifications, labeling, and artwork approvals — carry direct consequences for regulatory submissions, clinical supply continuity, and commercial readiness. When these decisions are made in isolation from the broader CMC and quality framework, they introduce unnecessary rework, submission delays, and cost overruns at the most critical stages of a program’s lifecycle. This alliance directly addresses that disconnect. 

A Complementary Partnership Across the Full Development Lifecycle 

The collaboration brings together DES Pharma Consulting’s expertise in CMC strategy, analytical development, quality assurance, regulatory compliance, supply chain management, and pharmacovigilance with Adept Packaging’s specialized capabilities in pharmaceutical packaging engineering, strategy, cost optimization, and commercial launch execution. 

DES Pharma Consulting supports biotech and pharmaceutical organizations from pre-clinical development through commercialization, providing integrated technical and regulatory expertise across five core functions: Program and Process Development, Analytics and Quality Control, Quality Assurance, Supply Chain and Procurement, and Medical Safety and Pharmacovigilance. The firm’s consultants bring direct experience across IND, BLA, and NDA submissions, technology transfers, GMP compliance programs, and pre-approval inspection readiness. 

Adept Packaging contributes specialized expertise in pharmaceutical and consumer packaging engineering, including primary and secondary packaging strategy, container closure qualification, artwork and labeling management, packaging line readiness, and cost transformation programs. The firm works exclusively within the pharmaceutical and life sciences sector, enabling clients to reduce packaging costs, accelerate artwork approvals, improve CDMO alignment, and build packaging strategies that hold up under FDA and global regulatory scrutiny. 

Together, the organizations are positioned to deliver continuity across the development stages where packaging and CMC strategy most frequently diverge — Phase 2 scale-up, Phase 3 clinical supply, and the transition to commercial manufacturing — reducing the coordination gaps that generate delay and risk at each handoff. 

Why This Alliance, Why Now 

“In today’s environment, companies are expected to move faster while maintaining the highest standards of quality and compliance,” said Meade Medaugh, CEO, DES Pharma Consulting. “This alliance allows us to better support clients by ensuring packaging is not an afterthought, but a fully integrated part of the development strategy.” 

The urgency behind that shift is well-founded. As more emerging biotech companies move toward commercialization with lean internal teams and CDMO-dependent supply chains, the organizational bandwidth to manage CMC and packaging strategy in a coordinated way is frequently limited. Programs that lack early packaging alignment routinely encounter late-stage surprises — material qualification failures, container closure incompatibilities, artwork revision cycles that push back submission timelines, or packaging line constraints that compress commercial launch windows. The cost of those surprises, measured in delayed revenue and regulatory risk, far exceeds the cost of early coordination. 

Adept Packaging shares that perspective from the packaging side of the equation. 

“Packaging decisions have a direct impact on regulatory outcomes, supply chain efficiency, and ultimately patient access,” said Jim Regan, Head of Packaging Consulting Services, Adept Packaging. “By collaborating with DES Pharma Consulting, we can help clients anticipate challenges earlier and execute with greater confidence.” 

Scope and Focus Areas 

The alliance is structured to benefit organizations across a range of development stages, with particular relevance to companies navigating late-stage clinical programs, pre-commercial planning, CDMO transitions, and global market expansion. Priority areas of collaboration include: 

Integrated development and packaging planning — embedding packaging strategy into CMC program timelines at Phase 2 and Phase 3, enabling earlier resolution of container closure, material qualification, and labeling requirements before they become submission-critical. 

Regulatory and quality alignment — ensuring packaging specifications, change control processes, and stability programs are developed in coordination with the broader quality management system and regulatory filing strategy, reducing the risk of findings at pre-approval inspection. 

Clinical-to-commercial supply chain transition — coordinating packaging line readiness, CMO and CDMO qualification, artwork approval workflows, and commercial sourcing strategies to compress the transition timeline and reduce launch risk. 

Cost and efficiency optimization — applying Adept Packaging’s value stream analysis and process engineering methodology within the context of DES Pharma Consulting’s supply chain and procurement expertise to identify cost reduction opportunities across the packaging supply base without compromising quality or compliance. 

As regulatory expectations continue to evolve and supply chains become increasingly complex, both organizations recognize that integrated development and packaging strategies are no longer optional for companies seeking to bring therapies to market efficiently and at scale. The alliance formalizes a model of collaboration designed to make that integration practical and accessible for organizations of all sizes. 

 

About DES Pharma Consulting 

DES Pharma Consulting is a pharmaceutical consulting firm dedicated to accelerating the path from lab to launch. The firm partners with emerging biotech and established pharmaceutical companies to deliver expert support across the full drug development lifecycle, including Program and Process Development, Analytics and Quality Control, Quality Assurance, Supply Chain and Procurement, and Medical Safety and Pharmacovigilance. With a team of senior consultants averaging more than 20 years of industry experience across small molecules, biologics, and advanced therapies, DES Pharma Consulting provides the technical depth and regulatory fluency its clients need to move programs forward with confidence. The firm has supported more than 25 regulatory filings, 30 technology transfers, and multiple commercial launches across global markets. 

 

About Adept Packaging 

Adept Packaging delivers best-in-class engineering, consulting, talent, sustainability and value optimization solutions for the packaging world. Adept works with biotech and pharmaceutical organizations at every stage of development — from early clinical through global commercial launch — to turn packaging from a bottleneck into a strategic advantage. Adept Packaging’s capabilities span packaging strategy and design, container closure and material qualification, labeling management, packaging process optimization, regulatory compliance, and organizational design. The firm has delivered documented cost savings of 10–25% across packaging operations for clients ranging from pre-commercial biotechs to large global pharmaceutical companies, while simultaneously improving speed to market and regulatory confidence.